Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc (1VRTX)

Market Open
10 Jan, 11:48
398. 70
+5.65
+1.44%
- Market Cap
- P/E Ratio
0% Div Yield
1 Volume
0 Eps
393.05
Previous Close
Day Range
397.05 398.7
Year Range
363.2 486.1
Earnings results expected in 20 days

Summary

1VRTX trading today higher at €398.7, an increase of 1.44% from yesterday's close, completing a monthly increase of 3.72% or €14.3. Over the past 12 months, 1VRTX stock gained 3.72%.
1VRTX is not paying dividends to its shareholders.
The last earnings report, released on Nov 04, 2024, exceeded the consensus estimates by 0.24%. On average, the company has fell short of earnings expectations by -6.57%, based on the last three reports. The next scheduled earnings report is due on Feb 03, 2025.
The stock of the company had never split.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on XMIL (EUR).
Want to track 1VRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

1VRTX Chart

FAQ

What Is the Vertex Pharmaceuticals Inc(1VRTX) Stock Price Today?

The 1VRTX stock price today is €398.70.

What Stock Exchange Does Vertex Pharmaceuticals Inc Trade On?

Vertex Pharmaceuticals Inc is listed and trades on the NASDAQ (NGS).

What Is the Stock Symbol for Vertex Pharmaceuticals Inc?

The stock symbol for Vertex Pharmaceuticals Inc is "1VRTX".

Does Vertex Pharmaceuticals Inc Pay Dividends? What's The Current Dividend Yield?

1VRTX is not paying dividends to its shareholders.

What Is the Vertex Pharmaceuticals Inc Market Cap?

As of today, Vertex Pharmaceuticals Inc does not have a market cap available.

What is Vertex Pharmaceuticals Inc Earnings Per Share?

The Vertex Pharmaceuticals Inc EPS is 0.

What Is the Next Vertex Pharmaceuticals Inc Earnings Date?

Vertex Pharmaceuticals Inc will release its next earnings report on Feb 03, 2025.

Did Vertex Pharmaceuticals Inc had any splits?

No, Vertex Pharmaceuticals Inc has never had a stock split.

Vertex Pharmaceuticals Inc Profile

Other Industry
Other Sector
- CEO
XMIL Exchange
US92532F1003 ISIN
DE Country
- Employees
- Last Dividend
- Last Split
- IPO Date
There is no Profile data available for VX1.BE.

Contact Information